Compile Data Set for Download or QSAR
Found 86 with Last Name = 'gushue' and Initial = 'j'
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233679(CHEMBL399284 | N-[3'-(5-carbamimidoyl-2-methylsulf...)copy SMILEScopy InChI
Affinity DataKi:  14nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233691(4-(2'-amino-6'-methyl-biphenyl-3-sulfonyl)-5-methy...)copy SMILEScopy InChI
Affinity DataKi:  20nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233674(6-{3-[3'-(5-carbamimidoyl-2-methylsulfanyl-thiophe...)copy SMILEScopy InChI
Affinity DataKi:  22nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233686(4-(2'-methyl-biphenyl-3-sulfonyl)-5-methylsulfanyl...)copy SMILEScopy InChI
Affinity DataKi:  30nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233688(4-(2'-chloro-biphenyl-3-sulfonyl)-5-methylsulfanyl...)copy SMILEScopy InChI
Affinity DataKi:  40nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233692(4-[3-(6-methyl-pyridin-2-yl)-benzenesulfonyl]-5-me...)copy SMILEScopy InChI
Affinity DataKi:  40nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233694(5-[3'-(5-carbamimidoyl-2-methylsulfanyl-thiophene-...)copy SMILEScopy InChI
Affinity DataKi:  42nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233677(4-(2'-hydroxymethyl-6'-methyl-biphenyl-3-sulfonyl)...)copy SMILEScopy InChI
Affinity DataKi:  50nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233689(5-methylsulfanyl-4-(6'-methyl-2'-{3-[2-(2H-tetrazo...)copy SMILEScopy InChI
Affinity DataKi:  64nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233680(4-(2'-hydroxymethyl-biphenyl-3-sulfonyl)-5-methyls...)copy SMILEScopy InChI
Affinity DataKi:  120nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233693(CHEMBL252619 | N-[3'-(5-carbamimidoyl-2-methylsulf...)copy SMILEScopy InChI
Affinity DataKi:  120nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233681(5-methylsulfanyl-4-(2'-vinyl-biphenyl-3-sulfonyl)-...)copy SMILEScopy InChI
Affinity DataKi:  140nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233676(3'-(5-carbamimidoyl-2-methylsulfanyl-thiophene-3-s...)copy SMILEScopy InChI
Affinity DataKi:  150nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233683(4-(3'-hydroxy-biphenyl-3-sulfonyl)-5-methylsulfany...)copy SMILEScopy InChI
Affinity DataKi:  150nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233678(4-(4'-hydroxy-biphenyl-3-sulfonyl)-5-methylsulfany...)copy SMILEScopy InChI
Affinity DataKi:  190nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233687(4-(4'-methyl-biphenyl-3-sulfonyl)-5-methylsulfanyl...)copy SMILEScopy InChI
Affinity DataKi:  250nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233675(4-(biphenyl-3-sulfonyl)-5-methylsulfanyl-thiophene...)copy SMILEScopy InChI
Affinity DataKi:  260nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233695(4-(4-methoxy-biphenyl-3-sulfonyl)-5-methylsulfanyl...)copy SMILEScopy InChI
Affinity DataKi:  350nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233690(4-(3-bromo-benzenesulfonyl)-5-methylsulfanyl-thiop...)copy SMILEScopy InChI
Affinity DataKi:  360nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233685(4-(2'-hydroxy-biphenyl-3-sulfonyl)-5-methylsulfany...)copy SMILEScopy InChI
Affinity DataKi:  460nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233682(4-(3-methoxy-biphenyl-3-sulfonyl)-5-methylsulfanyl...)copy SMILEScopy InChI
Affinity DataKi:  490nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233684(4-(2'-methoxy-biphenyl-3-sulfonyl)-5-methylsulfany...)copy SMILEScopy InChI
Affinity DataKi:  610nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetComplement C1s subcomponent(Homo sapiens (Human))
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50233696(4-(3'-methyl-biphenyl-3-sulfonyl)-5-methylsulfanyl...)copy SMILEScopy InChI
Affinity DataKi:  1.85E+3nMAssay Description:Inhibition of Complement C1s subcomponentMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2K35TD4PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166693(3-Pyridin-3-yl-3-{5-[2-(5,6,7,8-tetrahydro-[1,8]na...)copy SMILEScopy InChI
Affinity DataIC50: 0.25nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166695(3-(5-Methoxy-pyridin-3-yl)-3-{5-[2-(5,6,7,8-tetrah...)copy SMILEScopy InChI
Affinity DataIC50: 0.25nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166677(3-(5-Cyano-pyridin-3-yl)-3-{5-[2-(5,6,7,8-tetrahyd...)copy SMILEScopy InChI
Affinity DataIC50: 0.260nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166688(3-(6-Methanesulfonyl-pyridin-3-yl)-3-{5-[2-(5,6,7,...)copy SMILEScopy InChI
Affinity DataIC50: 0.300nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166678(3-Benzo[1,3]dioxol-5-yl-3-{5-[2-(5,6,7,8-tetrahydr...)copy SMILEScopy InChI
Affinity DataIC50: 0.380nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166683(3-Quinolin-3-yl-3-{5-[2-(5,6,7,8-tetrahydro-[1,8]n...)copy SMILEScopy InChI
Affinity DataIC50: 0.380nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166669(3-(5-Methanesulfonyl-pyridin-3-yl)-3-{5-[2-(5,6,7,...)copy SMILEScopy InChI
Affinity DataIC50: 0.460nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166675(3-(3-Chloro-phenyl)-3-{5-[2-(5,6,7,8-tetrahydro-[1...)copy SMILEScopy InChI
Affinity DataIC50: 0.5nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166680(3-(4-Methoxy-phenyl)-3-{5-[2-(5,6,7,8-tetrahydro-[...)copy SMILEScopy InChI
Affinity DataIC50: 0.700nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166668(3-(4-Fluoro-phenyl)-3-{5-[2-(5,6,7,8-tetrahydro-[1...)copy SMILEScopy InChI
Affinity DataIC50: 0.700nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166682(3-(3-Methoxy-phenyl)-3-{5-[2-(5,6,7,8-tetrahydro-[...)copy SMILEScopy InChI
Affinity DataIC50: 0.800nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166665(3-Pyridin-4-yl-3-{5-[2-(5,6,7,8-tetrahydro-[1,8]na...)copy SMILEScopy InChI
Affinity DataIC50: 0.900nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166691(3-Phenyl-3-{5-[2-(5,6,7,8-tetrahydro-[1,8]naphthyr...)copy SMILEScopy InChI
Affinity DataIC50: 1nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166692(3-(2-Methoxy-phenyl)-3-{5-[2-(5,6,7,8-tetrahydro-[...)copy SMILEScopy InChI
Affinity DataIC50: 1.10nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166673(3-Pyridin-2-yl-3-{5-[2-(5,6,7,8-tetrahydro-[1,8]na...)copy SMILEScopy InChI
Affinity DataIC50: 1.20nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166674(3-{5-[2-(5,6,7,8-Tetrahydro-[1,8]naphthyridin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166672(3-{5-[2-(5,6,7,8-Tetrahydro-[1,8]naphthyridin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 6nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166687(3-Benzo[1,3]dioxol-5-yl-3-{5-[2-(3,4-dihydro-2H-py...)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166679(3-{5-[3-(5,6,7,8-Tetrahydro-[1,8]naphthyridin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 23nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50161783(3-{5-[2-(6-Methylamino-pyridin-2-yl)-ethoxy]-indol...)copy SMILEScopy InChI
Affinity DataIC50: 36nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166666(3-Naphthalen-2-yl-3-{5-[2-(5,6,7,8-tetrahydro-[1,8...)copy SMILEScopy InChI
Affinity DataIC50: 37nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166686(3-Naphthalen-1-yl-3-{5-[2-(5,6,7,8-tetrahydro-[1,8...)copy SMILEScopy InChI
Affinity DataIC50: 37nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166685(3-Biphenyl-4-yl-3-{5-[2-(5,6,7,8-tetrahydro-[1,8]n...)copy SMILEScopy InChI
Affinity DataIC50: 40nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166690(3-(2-Chloro-phenyl)-3-{5-[2-(5,6,7,8-tetrahydro-[1...)copy SMILEScopy InChI
Affinity DataIC50: 55nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166671(3-{5-[2-(5,6,7,8-Tetrahydro-[1,8]naphthyridin-2-yl...)copy SMILEScopy InChI
Affinity DataIC50: 78nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166676(3-{5-[2,2-Difluoro-2-(5,6,7,8-tetrahydro-[1,8]naph...)copy SMILEScopy InChI
Affinity DataIC50: 130nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
TargetIntegrin alpha-V/beta-3(Homo sapiens (Human))
Johnson& Johnson, Pharmaceutical Research and Development, L.L.C.

Curated by ChEMBL
LigandPNGBDBM50166681(3-(5-{2-[N-(4,5-Dihydro-1H-imidazol-2-yl)-aminooxy...)copy SMILEScopy InChI
Affinity DataIC50: 200nMAssay Description:Inhibitory concentration against alphaV-beta3 integrinMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29Z40PubMed
Displayed 1 to 50 (of 86 total ) | Next | Last >>
Jump to: